Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:SEQUA - BE0974340722 - Common Stock

0.772 EUR
+0.08 (+11.08%)
Last: 11/28/2025, 10:09:08 AM
Fundamental Rating

1

Overall SEQUA gets a fundamental rating of 1 out of 10. We evaluated SEQUA against 63 industry peers in the Health Care Equipment & Supplies industry. SEQUA has a bad profitability rating. Also its financial health evaluation is rather negative. SEQUA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SEQUA had negative earnings in the past year.
In the past year SEQUA has reported a negative cash flow from operations.
In the past 5 years SEQUA always reported negative net income.
In the past 5 years SEQUA always reported negative operating cash flow.
SEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFSEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of SEQUA (-346.67%) is worse than 95.24% of its industry peers.
Industry RankSector Rank
ROA -346.67%
ROE N/A
ROIC N/A
ROA(3y)-300.31%
ROA(5y)-239.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEQUA.BR Yearly ROA, ROE, ROICSEQUA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

SEQUA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEQUA.BR Yearly Profit, Operating, Gross MarginsSEQUA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
SEQUA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SEQUA has been increased compared to 5 years ago.
SEQUA has a worse debt/assets ratio than last year.
SEQUA.BR Yearly Shares OutstandingSEQUA.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SEQUA.BR Yearly Total Debt VS Total AssetsSEQUA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

2.2 Solvency

SEQUA has an Altman-Z score of -30.36. This is a bad value and indicates that SEQUA is not financially healthy and even has some risk of bankruptcy.
SEQUA's Altman-Z score of -30.36 is on the low side compared to the rest of the industry. SEQUA is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.36
ROIC/WACCN/A
WACC5.79%
SEQUA.BR Yearly LT Debt VS Equity VS FCFSEQUA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 0.21 indicates that SEQUA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.21, SEQUA is doing worse than 93.65% of the companies in the same industry.
A Quick Ratio of 0.16 indicates that SEQUA may have some problems paying its short term obligations.
With a Quick ratio value of 0.16, SEQUA is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.16
SEQUA.BR Yearly Current Assets VS Current LiabilitesSEQUA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SEQUA have decreased strongly by -31.91% in the last year.
Looking at the last year, SEQUA shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
SEQUA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.84% yearly.
EPS 1Y (TTM)-31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.9%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%

3.2 Future

SEQUA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.21% yearly.
The Revenue is expected to grow by 465.03% on average over the next years. This is a very strong growth
EPS Next Y65.31%
EPS Next 2Y27.78%
EPS Next 3Y-14.21%
EPS Next 5YN/A
Revenue Next Year684.31%
Revenue Next 2Y710.47%
Revenue Next 3Y465.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SEQUA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SEQUA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEQUA.BR Price Earnings VS Forward Price EarningsSEQUA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEQUA.BR Per share dataSEQUA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A cheap valuation may be justified as SEQUA's earnings are expected to decrease with -14.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.78%
EPS Next 3Y-14.21%

More info and screens

0

5. Dividend

5.1 Amount

SEQUA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANA MEDICAL NV

EBR:SEQUA (11/28/2025, 10:09:08 AM)

0.772

+0.08 (+11.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-04 2025-09-04
Earnings (Next)N/A N/A
Inst Owners35.89%
Inst Owner ChangeN/A
Ins Owners5.35%
Ins Owner ChangeN/A
Market Cap50.77M
Revenue(TTM)N/A
Net Income(TTM)-52.00M
Analysts84
Price Target3.57 (362.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)43.96%
EPS NY rev (3m)43.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0
BVpS-0.59
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -346.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-300.31%
ROA(5y)-239.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.16
Altman-Z -30.36
F-Score2
WACC5.79%
ROIC/WACCN/A
Cap/Depr(3y)113.65%
Cap/Depr(5y)93.14%
Cap/Sales(3y)89.27%
Cap/Sales(5y)74.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.9%
EPS Next Y65.31%
EPS Next 2Y27.78%
EPS Next 3Y-14.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%
Revenue Next Year684.31%
Revenue Next 2Y710.47%
Revenue Next 3Y465.03%
Revenue Next 5YN/A
EBIT growth 1Y23.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.58%
OCF growth 3YN/A
OCF growth 5YN/A

SEQUANA MEDICAL NV / SEQUA.BR FAQ

What is the fundamental rating for SEQUA stock?

ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR.


What is the valuation status of SEQUANA MEDICAL NV (SEQUA.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to SEQUANA MEDICAL NV (SEQUA.BR). This can be considered as Overvalued.


How profitable is SEQUANA MEDICAL NV (SEQUA.BR) stock?

SEQUANA MEDICAL NV (SEQUA.BR) has a profitability rating of 0 / 10.


How financially healthy is SEQUANA MEDICAL NV?

The financial health rating of SEQUANA MEDICAL NV (SEQUA.BR) is 0 / 10.